Asbestos triggers inflammation by activating the Nalp3 inflammasome;Amiante et inflammation, rôle de l'inflammasome

Medecine/Sciences

Volumn 24, Issue 11, 2008, Pages 916-918

  Dostert, Catherine ^a   Pétrilli, Virginie ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; PROTEIN NALP3; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ASBESTOSIS; HUMAN; INFLAMMATION; LUNG FIBROSIS; MACROPHAGE; PHAGOCYTOSIS; PLEURA MESOTHELIOMA; SHORT SURVEY;

EID: 57149115164     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20082411916     Document Type: Short Survey

References (12)

1. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998 ; 157 : 1666-80.
2. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006 ; 7 : 1250-7.
3. Petrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome : a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007 ; 19 : 615-22.
4. Martinon F, Burns K, Tschopp J. The inflammasome : a molecular platform triggering activation of inflammatory caspases and processing of prolL-beta. Mol Cell 2002 ; 10 : 417-26.
5. Stojanov S, Kastner DL. Familial autoinflammatory diseases : genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005 ; 17 : 586-99.
6. Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006 ; 440 : 237-41.
7. Dostert C, Petrilli V, Van Bruggen R, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008 ; 320 : 674-7.
8. Cassel SL, Eisenbarth SC, Iyer SS, et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 2008 ; 105 : 9035-40.
9. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007 ; 9 : R28.
10. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003 ; 348 : 2583-4.
11. Delneste y, Beauvillain C, Jeannin P. Immunité naturelle : structure et fonction des Toll-like receptors. Med Sci (Paris) 2007 ; 23 : 67-73.
12. Guichard C, Pedruzzi E, Fay M, et al. Les Nox/Duox : une nouvelle famille de NADPH oxydases. Med Sci (Paris) 2006 ; 22 : 953-9.